
Pubmed-entry ::= {
  pmid 28641354,
  medent {
    em std {
      year 2017,
      month 6,
      day 23,
      hour 6,
      minute 0
    },
    cit {
      title {
        name "[Acute Liver Failure, Acute-On-Chronic Liver Failure,
 Hepatorenal Syndrome, Hepatopulmonary Syndrome and Portopulmonary
 Hypertension, Artificial Liver Support on the ICU].",
        trans "Akutes Leberversagen, akut-auf-chronisches Leberversagen,
 hepatorenales Syndrom, hepatopulmonales Syndrom und portopulmonale
 Hypertonie, Leberunterstutzungsverfahren auf der Intensivstation."
      },
      authors {
        names std {
          {
            name ml "Lodes U",
            affil str "Klinik fur Allgemein-, Viszeral- und Gefasschirurgie,
 Universitatsklinikum Magdeburg A. o. R., Deutschland."
          },
          {
            name ml "Jacob D",
            affil str "Klinik fur Allgemein-, Viszeral- und Gefasschirurgie,
 Universitatsklinikum Magdeburg A. o. R., Deutschland."
          },
          {
            name ml "Meyer F",
            affil str "Klinik fur Allgemein-, Viszeral- und Gefasschirurgie,
 Universitatsklinikum Magdeburg A. o. R., Deutschland."
          }
        }
      },
      from journal {
        title {
          iso-jta "Zentralbl Chir",
          ml-jta "Zentralbl Chir",
          issn "1438-9592",
          name "Zentralblatt fur Chirurgie"
        },
        imp {
          date std {
            year 2017,
            month 6
          },
          volume "142",
          issue "3",
          pages "275-286",
          language "ger",
          pubstatus ppublish,
          history {
            {
              pubstatus other,
              date std {
                year 2017,
                month 6,
                day 23,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus pubmed,
              date std {
                year 2017,
                month 6,
                day 24,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2018,
                month 7,
                day 12,
                hour 6,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pubmed 28641354,
        doi "10.1055/s-0043-106198",
        other {
          db "ELocationID doi",
          tag str "10.1055/s-0043-106198"
        }
      }
    },
    abstract "Background Acute hepatic dysfunction in the form of acute liver
 failure (ALF) or acute-on-chronic liver failure (ACLF) is a disease with a
 high risk of mortality and requires interdisciplinary intensive care. Aim
 This article explains the nomenclature, pathophysiology, prognosis and
 possible treatment options of ALF and ACLF, including the possibilities of
 extracorporeal liver support therapy at the point of liver transplantation
 (LTx). Method Narrative review with a selective literature review and
 representative case studies. Results/Corner Points ALF and ACLF may have
 several causes and are associated with high mortality. The causes of ALF must
 be accurately diagnosed because targeted treatment options are available.
 Both ALF and ACLF may require a liver transplantation for the patient's
 survival. For ALF and ACLF there are different criteria for decision-making
 on liver transplantation and graft allocation. For extracorporeal liver
 support therapy, two methods have been established (MARS [molecuar adsorbent
 recirculating system] and FPSA [fractionated plasma separation and
 adsorption] Prometheus((R))). Both approaches may have the potential to
 increase the probability of survival of patients with ALF or ACLF. In some
 cases they can be used for bridging to liver transplantation, in individual
 cases also for primary poison elimination, e.g. after Amatoxin ingestion.
 Both methods are not suitable for long-term therapy. Conclusion Acute liver
 failure (ALF) and acute on chronic liver failure (ACLF) are serious diseases
 with a high risk of mortality. Affected patients should receive immediate
 interdisciplinary intensive care in a (tertiary) centre with the aim to
 clarify the cause of the disease as well as possible treatment options with
 respect to available extracorporeal liver support therapy and liver
 transplantation.",
    mesh {
      {
        term "Acute-On-Chronic Liver Failure",
        qual {
          {
            subh "diagnosis"
          },
          {
            subh "mortality"
          },
          {
            mp TRUE,
            subh "therapy"
          }
        }
      },
      {
        term "Hepatopulmonary Syndrome",
        qual {
          {
            subh "diagnosis"
          },
          {
            subh "mortality"
          },
          {
            mp TRUE,
            subh "therapy"
          }
        }
      },
      {
        term "Hepatorenal Syndrome",
        qual {
          {
            subh "diagnosis"
          },
          {
            subh "mortality"
          },
          {
            mp TRUE,
            subh "therapy"
          }
        }
      },
      {
        term "Humans"
      },
      {
        term "Hypertension, Portal",
        qual {
          {
            subh "diagnosis"
          },
          {
            subh "mortality"
          },
          {
            mp TRUE,
            subh "therapy"
          }
        }
      },
      {
        term "Hypertension, Pulmonary",
        qual {
          {
            subh "diagnosis"
          },
          {
            subh "mortality"
          },
          {
            mp TRUE,
            subh "therapy"
          }
        }
      },
      {
        term "Intensive Care Units",
        qual {
          {
            subh "statistics & numerical data"
          }
        }
      },
      {
        term "Interdisciplinary Communication"
      },
      {
        term "Liver Failure, Acute",
        qual {
          {
            subh "diagnosis"
          },
          {
            subh "mortality"
          },
          {
            mp TRUE,
            subh "therapy"
          }
        }
      },
      {
        term "Liver Transplantation"
      },
      {
        mp TRUE,
        term "Liver, Artificial"
      },
      {
        term "Survival Rate"
      }
    },
    pmid 28641354,
    pub-type {
      "Journal Article",
      "Review"
    },
    status medline
  }
}


